Literature DB >> 10882595

Morbidity of pertussis in adolescents and adults.

G De Serres1, R Shadmani, B Duval, N Boulianne, P Déry, M Douville Fradet, L Rochette, S A Halperin.   

Abstract

The effect of age on the clinical presentation of pertussis was assessed in 664 adolescent and adult cases. Complications were more frequent in adults than in adolescents (28% vs. 16%). Pneumonia occurred in 2% of patients <30 years old but in 5%-9% of older patients. Urinary incontinence occurred in 34% of women >/=50 years old. Duration of cough, risk of sinusitis, and number of nights with disturbed sleep increased with smoking and asthma. The secondary attack rate in other household members >/=12 years was 11%. Pertussis in secondary case patients was less severe than in index case patients but presented with classic symptoms. The main source of infection in adolescents was schoolmates or friends; in adults it was workplace or their children. Teachers and health care workers had a greater risk of pertussis than did the general population. The burden of disease appears to increase with age, with smoking, and with asthma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882595     DOI: 10.1086/315648

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  69 in total

1.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Pertussis control in Canada.

Authors:  Scott A Halperin
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

3.  Is pertussis being considered as a cause of persistent cough among adults?

Authors:  Carine Couzigou; Antoine Flahault
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

4.  Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.

Authors:  A Polyzou; S Pournaras; U Dafni; D Sofianou; E Christeli; S Patrinos; A Tsakris
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

5.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

6.  Pertussis in Florida, 2000-2006: trends in a historically low-incidence state.

Authors:  Joann M Schulte; Robyn Kay; Janet J Hamilton; Cathy Mellinger; Phyllis Yambor; Christie Luce; Dawn Ginzl; Julia Gill; Richard S Hopkins
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

7.  [Vaccinations in adults--who? when? why?].

Authors:  F Hofmann
Journal:  Internist (Berl)       Date:  2005-02       Impact factor: 0.743

8.  Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, Canada.

Authors:  Michael Iskedjian; John H Walker; Gaston De Serres; Thomas R Einarson
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

9.  Enhanced surveillance for adverse events following immunization: Two years of dTap catch-up among high school students in Yukon, Canada (2004, 2005).

Authors:  Samara T David; Mhsc Colleen Hemsley; Paula E Pasquali; Bryce Larke; Jane A Buxton; Lee Y Lior
Journal:  Can J Public Health       Date:  2006 Nov-Dec

10.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.